Sheets Smith Wealth Management Abbott Laboratories Transaction History

Sheets Smith Wealth Management

$789 Million
Q1 2025

A detailed history of Sheets Smith Wealth Management transactions in Abbott Laboratories stock. As of the latest transaction made, Sheets Smith Wealth Management holds 2,971 shares of ABT stock, worth $398,500. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,971

Previous 2,996 0.83%

Holding current value

$398,500

Previous $338,000 16.57%

% of portfolio

0.05%

Previous 0.04%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 23, 2025	SELL	$111.1 - $140.22 $2,777 - $3,505	-25 Reduced 0.83%	2,971 $394,000
Q4 2024 Jan 17, 2025	BUY	$111.93 - $119.39 $559 - $596	5 Added 0.17%	2,996 $338,000
Q3 2024 Nov 01, 2024	BUY	$100.07 - $118.13 $700 - $826	7 Added 0.23%	2,991 $341,000
Q2 2024 Jul 30, 2024	BUY	$100.73 - $112.44 $604 - $674	6 Added 0.2%	2,984 $310,000
Q1 2024 May 08, 2024	BUY	$109.52 - $120.96 $766 - $846	7 Added 0.24%	2,978 $338,000
Q4 2023 Feb 06, 2024	SELL	$90.19 - $110.4 $59,615 - $72,974	-661 Reduced 18.2%	2,971 $327,000
Q3 2023 Oct 23, 2023	BUY	$95.53 - $114.62 $764 - $916	8 Added 0.22%	3,632 $351,000
Q2 2023 Aug 09, 2023	BUY	$100.78 - $112.29 $806 - $898	8 Added 0.22%	3,624 $395,000
Q1 2023 May 26, 2023	BUY	$96.86 - $114.01 $340,462 - $400,745	3,515 Added 3480.2%	3,616 $366,000
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $339,688 - $399,833	-3,507 Reduced 97.2%	101 $10,000
Q4 2022 Mar 08, 2023	SELL	$95.06 - $111.52 $35,647 - $41,820	-375 Reduced 9.42%	3,608 $396,000
Q3 2022 Nov 01, 2022	SELL	$96.76 - $112.03 $5,612 - $6,497	-58 Reduced 1.44%	3,983 $385,000
Q2 2022 Jul 27, 2022	SELL	$102.07 - $123.37 $40,113 - $48,484	-393 Reduced 8.86%	4,041 $439,000
Q1 2022 May 02, 2022	BUY	$114.02 - $139.04 $1,254 - $1,529	11 Added 0.25%	4,434 $525,000
Q4 2021 Jan 20, 2022	SELL	$115.53 - $141.46 $139,213 - $170,459	-1,205 Reduced 21.41%	4,423 $622,000
Q3 2021 Oct 15, 2021	SELL	$116.66 - $129.06 $37,681 - $41,686	-323 Reduced 5.43%	5,628 $665,000
Q2 2021 Aug 03, 2021	SELL	$105.79 - $124.53 $602,050 - $708,700	-5,691 Reduced 48.88%	5,951 $690,000
Q1 2021 Apr 23, 2021	BUY	$108.84 - $128.23 $15,672 - $18,465	144 Added 1.25%	11,642 $1.4 Million
Q4 2020 Jan 13, 2021	BUY	$105.0 - $114.42 $8,820 - $9,611	84 Added 0.74%	11,498 $1.26 Million
Q3 2020 Oct 26, 2020	BUY	$91.64 - $111.29 $617,287 - $749,649	6,736 Added 143.99%	11,414 $1.24 Million
Q2 2020 Jul 17, 2020	SELL	$76.57 - $98.0 $1.14 Million - $1.46 Million	-14,892 Reduced 76.1%	4,678 $428,000
Q1 2020 Apr 28, 2020	SELL	$62.82 - $91.86 $172,880 - $252,798	-2,752 Reduced 12.33%	19,570 $1.54 Million
Q4 2019 Jan 24, 2020	SELL	$78.51 - $87.4 $36,036 - $40,116	-459 Reduced 2.01%	22,322 $1.93 Million
Q3 2019 Oct 28, 2019	SELL	$81.84 - $88.74 $42,720 - $46,322	-522 Reduced 2.24%	22,781 $1.91 Million
Q2 2019 Jul 12, 2019	SELL	$72.88 - $85.0 $54,076 - $63,070	-742 Reduced 3.09%	23,303 $1.96 Million
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $132 - $160	-2 Reduced 0.01%	24,045 $1.92 Million
Q4 2018 Jan 11, 2019	BUY	$65.56 - $74.27 $223,952 - $253,706	3,416 Added 16.56%	24,047 $1.74 Million
Q3 2018 Oct 15, 2018	BUY	$60.81 - $73.36 $11,432 - $13,791	188 Added 0.92%	20,631 $1.51 Million
Q2 2018 Jul 26, 2018	BUY	$57.57 - $63.54 $402 - $444	7 Added 0.03%	20,443 $1.25 Million
Q1 2018 Apr 09, 2018	SELL	$56.27 - $63.62 $23,070 - $26,084	-410 Reduced 1.97%	20,436 $1.23 Million
Q4 2017 Jan 12, 2018	BUY	$53.68 - $57.47 $24,907 - $26,666	464 Added 2.28%	20,846 $1.19 Million
Q3 2017 Oct 12, 2017	BUY	$48.06 - $53.64 $979,558 - $1.09 Million	20,382	20,382 $1.09 Million

Others Institutions Holding ABT

# of Institutions

3,544

Shares Held

1.38B

Call Options Held

9.75M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $235B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheets Smith Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Sheets Smith Wealth Management with notifications on news.

Account

Sheets Smith Wealth Management Abbott Laboratories Transaction History